Analysis Madrigal Pharmaceuticals Inc (MDGL)
6/3/2024
Analysis of Madrigal Pharmaceuticals Inc (MDGL)
Madrigal Pharmaceuticals Inc (MDGL) has shown some interesting price movements recently. The stock closed at $236.16 on May 31st, with an RSI indicator of 57.53, indicating a slightly overbought condition. The MACD indicator is positive at 1.86, suggesting bullish momentum.Looking at the moving averages, the Simple Moving Average (SMA) stands at $221.28, the Exponential Moving Average (EMA) at $225.20, and the Weighted Moving Average (WMA) at $222.82. The stock price is above all these moving averages, indicating a bullish trend.
Overall, based on the RSI, MACD, and moving averages, Madrigal Pharmaceuticals Inc appears to be in a bullish phase. However, investors should continue to monitor the indicators for any signs of a potential reversal in the trend.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and key financial figures include EBITDA, revenue, diluted EPS, gross profit, and net income.
Moving on to stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock has a certain percentage held by insiders, and there is information on shares outstanding, float shares, and average trading volumes.
Valuation metrics show the company's price-to-earnings ratios, price-to-book ratio, price-to-sales ratio, and other valuation multiples. The market capitalization and enterprise value provide insights into the company's overall value in the market.
The stock price summary includes beta, moving averages, and the range of the stock price over the past fifty-two weeks. This information can be useful for technical analysis and understanding the stock's volatility.
Lastly, dividends and splits data show the company's dividend history, payout ratio, dividend dates, and dividend yields. Information on dividend rates, split history, and average dividend yield over five years is also provided.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased from $3.28 in 2020 to $6.16 in 2023.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been able to control its operating expenses effectively, allowing for growth in operating income.
9. Non-operating interest expenses have been relatively stable over the years.
10. The number of basic and diluted shares outstanding has remained constant, indicating no significant changes in share issuance.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets have been increasing over the years, indicating growth in the company's overall value.
2. Current assets have fluctuated, with some years showing higher cash reserves and others showing higher inventory levels.
3. Non-current assets have generally increased, especially in investments and advances.
4. Total liabilities have also been on the rise, but at a slower pace compared to total assets.
5. Shareholders' equity has shown variations, with retained earnings playing a significant role.
6. The company seems to be investing heavily in non-current assets and long-term debt, which could indicate expansion plans.
7. Overall, the financial health of the company appears stable, with a good balance between assets, liabilities, and equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, long-term debt issuance, and payments, with significant fluctuations in values.
6. Investing activities indicate a mix of acquisitions, investments, and capital expenditures, with varying levels of cash flow each year.
7. Overall, the company's financial performance seems to be stable, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and fiscal years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates remains at 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates increases to 38.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
These estimates suggest a moderate but steady growth trend in both quarterly and annual sales for the company, with a more significant increase expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years was 20.1%
It appears that the company is expected to experience a significant slowdown in growth compared to the past 5 years, with a lower growth rate projected for the current year and next quarter. However, there is optimism for a higher growth rate in the next year and over the next 5 years compared to the current year and next quarter.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median estimate above the current price. However, there is a wide range of estimates, from $164 to $275, indicating some uncertainty in the predictions.
MACD of MDGL
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
